A0516 – Metabolic benefits of adding metformin to androgen deprivation therapy for patients with metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Results from the STAMPEDE metformin trial

Saved in:
Bibliographic Details
Published in:European urology Vol. 87; pp. S1336 - S1337
Main Authors: Sachdeva, A., Gillessen, S., Murphy, L., El-Taji, O., Gray, S., Attard, G., Jones, R., Adler, A., Millman, R., Matheson, D., Amos, C., Murphy, C., C., McAlpine, Parmar, M., Brown, L., James, N.D., Clarke, N.W.
Format: Journal Article
Language:English
Published: Elsevier B.V 01.03.2025
Subjects:
ISSN:0302-2838
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0302-2838
DOI:10.1016/j.eururo.2025.09.3706